#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemolytic uraemic syndrome Acute respiratory distress syndrome Metastatic gastric cancer Laryngeal squamous cell carcinoma Immune thrombocytopenia Polymyositis Central nervous system neoplasm Leukocyte adhesion deficiency type I Crohn's disease Biotinidase deficiency Neurofibroma Breast angiosarcoma metastatic Trigeminal neuralgia Human papilloma virus immunisation Infertility male More trials…

    Learn about Rare Diseases

    Inclusion body myositis – Basic Information Breast angiosarcoma – Treatment Nephrotic syndrome – Trials in Disease Lysosomal storage disorder – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Krabbe’s disease – Trials in Disease Bronchiolitis obliterans syndrome – Life with Disease Alagille syndrome – Basic Information Paraneoplastic neurological syndrome Hereditary optic atrophy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mosliciguat Azd7798 Bi 1839100 Etoposide Tramazoline Hydrochloride Omalizumab Eftilagimod Alfa Lidocaine ANOC-001 Saruparib Voclosporin GSKVX000000034795 Wt1 Lamp Mrna Dc Fedratinib Etifoxine Hydrochloride 19Cp02 Bi 1819479 Human Vaccinia Immunoglobulin Lifileucel Colesevelam More therapies…

    Learn about Your Condition

    Ectopic pregnancy Escherichia infection Prinzmetal angina Neuropathic arthropathy Thyroidectomy Double hit lymphoma Ependymoma malignant Genital infection female HER2 positive breast cancer Liposarcoma metastatic Mitral valve disease Arthralgia Facial paresis Childhood asthma Apheresis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparison of ampicillin plus gentamicin versus piperacillin/tazobactam for empirical treatment of hospitalized patients with community‑acquired infection

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    • Pyelonephritis
    • Sepsis
    Investigated Drugs:
    • Ampicillin Sodium
    • Betamethasone Valerate
    • Gentamicin Sulfate
    Denmark

  • Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Sodium Chloride
    Bulgaria Czechia Germany Hungary Poland Spain

  • Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    France

  • Discontinuing vs Continuing Riociguat in Chronic Thromboembolic Pulmonary Hypertension Patients After Successful Balloon Pulmonary Angioplasty

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Riociguat
    France

  • Safety of Two Doses of Siplizumab Compared with Rabbit Anti‑Human Thymocyte Immunoglobulin in Kidney Transplant Recipients Receiving Standard Immunosuppression

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Siplizumab
    Czechia Portugal Spain

  • Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Pitolisant
    Belgium Germany Italy Poland Spain
Previous Page
1 … 655 656 657 658 659 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!